Analysts Set Inspire Medical Systems, Inc. (NYSE:INSP) Price Target at $271.29

Shares of Inspire Medical Systems, Inc. (NYSE:INSPGet Free Report) have earned an average recommendation of “Moderate Buy” from the thirteen analysts that are presently covering the stock, MarketBeat.com reports. Four research analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $271.29.

Several equities research analysts have issued reports on the stock. Stifel Nicolaus restated a “hold” rating and set a $210.00 price objective on shares of Inspire Medical Systems in a research report on Tuesday, January 2nd. Jefferies Financial Group began coverage on Inspire Medical Systems in a report on Friday, January 19th. They issued a “buy” rating and a $245.00 price objective on the stock. Mizuho lifted their target price on Inspire Medical Systems from $225.00 to $250.00 and gave the stock a “buy” rating in a report on Wednesday, February 7th. Wells Fargo & Company cut shares of Inspire Medical Systems from an “overweight” rating to an “equal weight” rating and reduced their target price for the company from $245.00 to $187.00 in a research report on Wednesday, December 13th. Finally, Truist Financial reaffirmed a “buy” rating and set a $280.00 price target on shares of Inspire Medical Systems in a research report on Wednesday.

Check Out Our Latest Stock Analysis on Inspire Medical Systems

Insider Activity

In other Inspire Medical Systems news, insider Randy Ban sold 3,060 shares of the company’s stock in a transaction on Tuesday, February 27th. The stock was sold at an average price of $182.01, for a total transaction of $556,950.60. Following the completion of the sale, the insider now directly owns 3,029 shares in the company, valued at $551,308.29. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Inspire Medical Systems news, insider Randy Ban sold 3,060 shares of Inspire Medical Systems stock in a transaction dated Tuesday, February 27th. The stock was sold at an average price of $182.01, for a total value of $556,950.60. Following the transaction, the insider now owns 3,029 shares in the company, valued at $551,308.29. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Jerry C. Griffin sold 554 shares of the business’s stock in a transaction dated Monday, March 11th. The stock was sold at an average price of $198.05, for a total value of $109,719.70. Following the transaction, the director now directly owns 9,744 shares of the company’s stock, valued at approximately $1,929,799.20. The disclosure for this sale can be found here. In the last ninety days, insiders sold 16,398 shares of company stock worth $3,040,961. 4.50% of the stock is currently owned by corporate insiders.

Institutional Trading of Inspire Medical Systems

Hedge funds have recently added to or reduced their stakes in the stock. Resurgent Financial Advisors LLC acquired a new stake in shares of Inspire Medical Systems during the 2nd quarter valued at $25,000. McGlone Suttner Wealth Management Inc. acquired a new stake in shares of Inspire Medical Systems during the fourth quarter valued at about $27,000. Altshuler Shaham Ltd bought a new stake in shares of Inspire Medical Systems during the fourth quarter worth about $29,000. NBC Securities Inc. acquired a new position in shares of Inspire Medical Systems in the third quarter valued at approximately $34,000. Finally, Parkside Financial Bank & Trust bought a new position in Inspire Medical Systems in the 1st quarter valued at approximately $37,000. Institutional investors and hedge funds own 94.91% of the company’s stock.

Inspire Medical Systems Stock Up 1.1 %

NYSE:INSP opened at $197.39 on Wednesday. Inspire Medical Systems has a 12-month low of $123.27 and a 12-month high of $330.00. The stock’s 50 day moving average price is $196.89 and its two-hundred day moving average price is $182.05. The firm has a market capitalization of $5.98 billion, a price-to-earnings ratio of -266.74 and a beta of 1.35.

Inspire Medical Systems (NYSE:INSPGet Free Report) last announced its quarterly earnings results on Tuesday, February 6th. The company reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.53. Inspire Medical Systems had a negative return on equity of 3.93% and a negative net margin of 3.39%. The business had revenue of $192.51 million during the quarter, compared to the consensus estimate of $186.75 million. During the same quarter last year, the firm posted $0.10 EPS. The company’s quarterly revenue was up 39.6% on a year-over-year basis. Equities research analysts expect that Inspire Medical Systems will post -0.35 EPS for the current year.

Inspire Medical Systems Company Profile

(Get Free Report

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.

Further Reading

Analyst Recommendations for Inspire Medical Systems (NYSE:INSP)

Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.